We are live on ! Find out more
FHTX icon

Foghorn Therapeutics
FHTX

47 hedge funds and large institutions have $470M invested in Foghorn Therapeutics in 2020 Q4 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

65.03% more ownership

Funds ownership: 0% → 65.03% (+65%)

Holders
47
Holders Change
+47
Holders Change %
–
% of All Funds
0.83%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.07%
New
47
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FP
Flagship Pioneering
Massachusetts
+$243M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$49.4M
3
AG
Artal Group
Luxembourg
+$33M
4
CAM
Cormorant Asset Management
Massachusetts
+$19.2M
5
BlackRock
BlackRock
New York
+$12.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$257M +$243M +12,674,120 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$50.1M +$49.4M +2,580,634 New
AG
3
Artal Group
Luxembourg
$34.9M +$33M +1,720,720 New
EC
4
Euclidean Capital
New York
$25.6M +$24.2M +1,261,261 New
CAM
5
Cormorant Asset Management
Massachusetts
$20.3M +$19.2M +1,000,000 New
BlackRock
6
BlackRock
New York
$13.6M +$12.9M +672,204 New
MIM
7
Monashee Investment Management
Massachusetts
$11.4M +$10.7M +560,360 New
AI
8
Alphabet Inc
California
$10.2M +$9.6M +500,901 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$8.18M +$7.73M +403,451 New
BC
10
Birchview Capital
Vermont
$6.37M +$6.02M +314,143 New
SCM
11
Suvretta Capital Management
New York
$5.24M +$4.96M +258,700 New
CC
12
Casdin Capital
New York
$4.38M +$4.14M +216,216 New
Millennium Management
13
Millennium Management
New York
$4.36M +$4.12M +214,862 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$2.69M +$2.54M +132,512 New
WP
15
Woodline Partners
California
$2.09M +$1.97M +103,040 New
State Street
16
State Street
Massachusetts
$2.06M +$1.95M +101,796 New
PAMU
17
Pictet Asset Management (UK)
United Kingdom
$2.01M +$1.9M +99,237 New
Victory Capital Management
18
Victory Capital Management
Texas
$1.89M +$1.78M +93,070 New
Northern Trust
19
Northern Trust
Illinois
$1.79M +$1.69M +88,438 New
Charles Schwab
20
Charles Schwab
California
$932K +$880K +45,956 New
Morgan Stanley
21
Morgan Stanley
New York
$867K +$819K +42,744 New
BOTOTLSJU
22
Board of Trustees of The Leland Stanford Junior University
California
$621K +$587K +30,657 New
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$566K +$535K +27,939 New
JP Morgan Chase
24
JP Morgan Chase
New York
$399K +$376K +19,639 New
HSBC Holdings
25
HSBC Holdings
United Kingdom
$385K +$362K +18,900 New
1
2

FHTX Hedge Fund Activity: Q4 2020 in Review

47 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q4 2020, worth a combined $470M.

Buyers outnumbered sellers: 47 funds opened new FHTX positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Flagship Pioneering, opening a new position worth an estimated $243M.

  • 47 institutional investors held Foghorn Therapeutics (FHTX) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $470M of Foghorn Therapeutics stock for Q4 2020.
  • 47 funds opened new Foghorn Therapeutics positions in Q4 2020 and 0 closed out, a net change of +47 holders.
  • The largest Foghorn Therapeutics buyer in Q4 2020 was Flagship Pioneering, an estimated $243M added.

Based on aggregated 13F filings for Q4 2020.